Part one of this three-part series examines the rational for using control technology to reduce process variability ...
Pfizer's Conor Riordan explains how the pharmaceutical giant uses Celonis across 200+ markets to drive toward 95% order ...
Automated insulin delivery was improved with improved glycemic control metrics among patients with type 2 diabetes regardless of C-peptide levels.
A modelling tool can estimate the longevity of a variety of CIEDs, allowing clinicians to choose the most appropriate device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results